Light Chain Multiple Myeloma: A Single Institution Series

Antonio Romero², Manuel Jurado^1,2,3, Juan Sáinz^1,2,3, Fernando Jaén¹⁰, Emilio Martínez⁹, Lucía Moratalla², Elisa López-Fernández², Pilar Garrido², Miguel Ángel Calleja-Hernández⁸, Rafael Ríos-Tamayo^1,2,3*, Carolina Alarcón-Payer⁸, Pedro Antonio González², Daysi-Yoe-Ling Chang^4,6, José Manuel Puerta², Teresa Rodríguez⁷, José Luís García De Veas⁷ and María José Sánchez^4,5,6

¹Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves, Granada, Spain

²Department of Hematology, University Hospital Virgen de las Nieves, Granada, Spain

³Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer /University of Granada / Andalusian Regional Government, PTS, Granada, Spain

⁴Granada Cancer Registry, Andalusian School of Public Health, Granada, Spain

⁵CIBER Epidemiology and Public Health, Granada, Spain

⁶Instituto de Investigación Biosanitaria de Granada (Ibs.GRANADA), Hospitales Universitarios de Granada / Universidad de Granada, Granada, Spain

⁷Department of Inmunology, University Hospital Virgen de las Nieves, Granada, Spain

⁸Department of Pharmacy, University Hospital Virgen de las Nieves, Granada, Spain

⁹Department of Nephrology, University Hospital Virgen de las Nieves, Granada, Spain

¹⁰Department of Internal Medicine, University Hospital Virgen de las Nieves, Granada, Spain

^*Corresponding Author: Rafael Ríos-Tamayo, MD, University Hospital Virgen de las Nieves, Granada, Spain, Tel: +34671592298 Email: